Dr Pierre Martin-Hirsch
Job title: Consultant Gynaecological Oncologist and Gynaecologist
Department: Obstetrics and Gynaecology
Telephone number: 01772 524442
Primary medical qualification: MBCHB
Other qualifications: BSc FROG MD
Year of registration: 1987
GMC number: 420391
Specialist training in obstetrics and gynaecology, NW Deanery .
Wellbeing Research Fellow, St James's University Hospital, Leeds
RCOG Subspecialty Trainee/ Lecturer in Gynaecological Oncology, Manchester University / Christie / St Mary’s Hospital .
Consultant Gynaecological Oncologist and Gynaecologist for Lancashire Teaching Hospitals NHS Foundation Trust (2001-present),
Trust Lead for Gynaecological Oncology
Hon Professor Lancaster University , Hon SL UCLAN, Editor BJOG & Secretary of British Colposcopy Society, Executive Board of International Federation of Colposcopy , North West Coastal research network lead for Reproductive Health and Gynaecological Oncology
Specialist areas: Gynaecological oncology; colposcopy; vulval / vaginal precancer; oncology training
Specialist Interests: Minimal access surgery, Vulval disorders , colposcopy, ovarian cancer surgery, patient information
Research interests: Evidence Based Practice in Gynaecological oncology, Imaging, Surgery in ovarian Cancer, Follow-up care, Patient information, Translational research, outcomes after treatment of cervical pre-cancer. >100 published papers. Supervision of academic trainees, clinical research fellows undertaking MDs, PHD students.
Clinics: Gynaecological Oncology Clinic; Colposcopy Clinic; Vulva CLinic; Gynaecology Clinic
Improving Outcomes in Gynaecological Oncology;
H.C. Kitchener, P.L. Martin-Hirsch 1997 NHS Executive
Pilot Study of Photodynamic Therapy For VIN / CIN
P.L. Martin-Hirsch, HC. Kitchener 1997 Central Manchester R+D
Supra-regional Audit of Maternity Care for Pregnant Adolescents
M.W. Seif, P.L. Martin-Hirsch, M. Maresh 1998 North West R+D
R.C.T. evaluating strategies to improve compliance for colposcopyA. Tomlinson, P.L. Martin-Hirsch 1998
Central Manchester R+D
R.C.T evaluating a novel collection device for cervical cytology
P.L. Martin-Hirsch, H. Kitchener 2000 Ampersand International
Cochrane / Systematic Reviews in Cervical Screening
P.L. Martin-Hirsch., M. Arbyn 2005 Cochrane Collaboration
Characterisation of cervical cells employing photothermal micro-spectroscopy +
Characterisation of DNA adducts in endometrium 2005+2006
P.L. Martin-Hirsch, F. Martin .LTHT and Rosemere Cancer Charity
Synucleins as Biomarkers and Potential Targets for Intervention in Cancer Progression
Dr. O El-Agnaf, P.Martin-Hirsch, S Aswad, F Martin 2005
Terry Fox Fund for Cancer Research
Human Ovarian Cancer: Stem Cells & Drug Resistance 2006
Professor Hassan T Hassan, P.L. Martin-Hirsch
NHS Cochrane Collaboration Programme Grant Scheme
Diagnosis and treatment of gynaecological cancer: improving the evidence for the NHS 2007
Khalid Khan, Sudha Sundhar, Pierre Martin-Hirsch, Trcey Roberts, Peter Guest Clinical Effectiveness of PET-CT imaging in restaging cervical cancer: systematic review and economic modelling: HTA June 2010
Andrea Rockall, Jon Hill, Pierre Martin-Hirsch, Sundha Sudhar, Richard Edmunson and Colleagues Prospective study evaluating PET in diagnosing lymph node disease in uterine and cervical cancer: Preston / Barts / Cambridge / Birmingham CRUK funded Nov 2010
C. Williams, P. Martin-Hirsch, R. Naik, J. Morrison S. Kehoe Optimising care, diagnosis and treatment pathways to ensure cost effectiveness and best practice in gynaecological cancer: improving the evidence for the NHS: NIHR Cochrane Collaboration Programme Grant Scheme Jan 2011
K. Beaver, P. Martin-Hirsch A.Tomlinson, S Williamson, C. Sutton Comparing hospital and telephone follow-up for women treated for endometrial cancer (ENDOCAT: Endometrial Cancer telephone follow-up trial. RFPB April 2011
Towards disease diagnosis through spectrochemical imaging of tissue architecture.
Engineering and Physics Research Council April 2013 : Weightman and colleagues.
Liverpool / Lancaster Universities I am a clinical partner with Lancashire Teaching Hospitals as the healthcare partner
Development of multimedia patient information resources for all cancers; Rosemere Cancer Charity 2014
A research trial that could stop millions of women from developing cervical cancer
Our Oncology and Research teams are working in partnership with The University of Manchester and Douglas Pharmaceuticals to develop a new treatment of early-stage cervical cancer.
The research is looking into whether a drug, commonly used to treat HIV, might prevent early-stage cervical cancer.
Dr. Pierre Martin-Hirsch, our Consultant Gynaecological Oncologist and Director of Research will be leading the clinical trial in the UK; he said: “This is a really exciting project and something that I am incredibly proud to be involved in. This new treatment could offer hope for millions of women across the world who are at risk of cervical cancer.
A clinical trial to try and develop this treatment is due to start in early 2018.